ANDREONI, MARTINO MARIO
 Distribuzione geografica
Continente #
EU - Europa 331
NA - Nord America 263
AS - Asia 113
SA - Sud America 6
AF - Africa 4
Totale 717
Nazione #
US - Stati Uniti d'America 247
IT - Italia 109
DE - Germania 98
CN - Cina 78
GB - Regno Unito 66
IE - Irlanda 18
CA - Canada 13
SE - Svezia 13
SG - Singapore 13
IN - India 11
FR - Francia 7
FI - Finlandia 6
BR - Brasile 5
HK - Hong Kong 4
DK - Danimarca 3
ES - Italia 3
ID - Indonesia 3
MX - Messico 3
BE - Belgio 2
GA - Gabon 2
JP - Giappone 2
RU - Federazione Russa 2
UG - Uganda 2
AM - Armenia 1
CL - Cile 1
MY - Malesia 1
NL - Olanda 1
NO - Norvegia 1
RO - Romania 1
UA - Ucraina 1
Totale 717
Città #
Frankfurt am Main 85
Southend 55
Chandler 45
Fairfield 35
Rome 26
Milan 25
Dublin 18
Ashburn 17
Seattle 16
Houston 14
Beijing 13
Dearborn 12
Wilmington 12
Woodbridge 12
Princeton 10
Grafing 9
Toronto 9
Ann Arbor 7
Guangzhou 7
Phoenix 7
Cambridge 6
Helsinki 6
Jinan 6
Redwood City 6
Singapore 6
Zhengzhou 6
Bengaluru 5
Nanjing 5
Shanghai 5
Boardman 4
Des Moines 4
Brescia 3
Changsha 3
Chongqing 3
Genova 3
Jakarta 3
Kunming 3
Ludwigshafen 3
Montréal 3
Puebla City 3
Ascoli Piceno 2
Bologna 2
Brussels 2
Central District 2
Chengdu 2
Falls Church 2
Fremont 2
Hong Kong 2
Jiaxing 2
Kampala 2
London 2
Messina 2
Mumbai 2
Pune 2
Saginomiya 2
Tianjin 2
Chaoyang 1
Chiavari 1
Chieti 1
Civitanova Marche 1
Césarches 1
Dallas 1
Dubino 1
Durham 1
Edinburgh 1
Fairfax 1
Ferrara 1
Fishers 1
Gioia Del Colle 1
Haikou 1
Kota Bharu 1
Moscow 1
Nantong 1
Ningbo 1
Nuremberg 1
Oslo 1
Ottawa 1
Padova 1
Palermo 1
Paulista 1
Ponsacco 1
Quartu Sant'elena 1
Rho 1
Roxbury 1
Saint Albans 1
Saint Louis 1
San Cesareo 1
San Diego 1
San Mateo 1
Sesto San Giovanni 1
Shenyang 1
Taizhou 1
Taramani 1
Trapani 1
Trento 1
Turin 1
Valencia 1
Vladimir 1
Washington 1
Wellington 1
Totale 596
Nome #
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 402
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 117
Thymic-and bone marrow-cellular reservoirs harbor phylogenetically distinct HIV strains and different resistance profiles 104
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 77
Fib4 is an independent predictor of serious liver disease among HIV-infected patients with or without HBV/HCV co-infection in the Icona foundation study 50
Totale 750
Categoria #
all - tutte 2.365
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.365


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020200 20 7 9 25 18 20 30 20 18 16 6 11
2020/2021122 12 6 2 7 1 17 7 14 20 26 9 1
2021/202282 2 6 7 10 8 3 1 7 13 7 2 16
2022/2023126 14 16 6 11 17 14 2 14 25 0 6 1
2023/2024158 3 5 9 12 20 15 16 12 6 22 17 21
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 750